Equities

Cambridge Nutritional Sciences PLC

Cambridge Nutritional Sciences PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)3.20
  • Today's Change0.00 / 0.00%
  • Shares traded1.28m
  • 1 Year change+36.17%
  • Beta4.5768
Data delayed at least 20 minutes, as of Nov 11 2024 15:48 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cambridge Nutritional Sciences plc is a United Kingdom-based diagnostics testing company. The principal activities of the Company are the manufacture, development and distribution of medical diagnostics products for the food sensitivity testing market. The Company’s segments include Health and Nutrition, and Corporate. The Health and Nutrition division specializes in the research, development and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis for the general public, clinics and health professionals as well as supplying the point-of-care Food Detective test. Its range of food sensitivity and functional health tests can help identify the root cause of gut health issues. Its brands include FoodPrint, Food Detective, CNSLab, and My Health Tracker. The Company has a global customer base across more than 75 countries, and its products are used by more than 170 laboratories worldwide.

  • Revenue in GBP (TTM)9.77m
  • Net income in GBP-328.00k
  • Incorporated2004
  • Employees94.00
  • Location
    Cambridge Nutritional Sciences PLCEden Research ParkHenry Crabb Road, LittleportELY CB6 1SEUnited KingdomGBR
  • Phone+44 135 386 2220
  • Fax+44 125 976 1853
  • Websitehttps://www.omegadx.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Deltex Medical Group plc1.78m-1.29m1.71m37.00--0.5862--0.9581-0.0007-0.00070.0010.00150.31560.91135.2348,135.14-22.92-14.66-35.89-21.8162.2171.84-72.60-32.930.4855-3.310.4245---28.44-18.55-11.97--9.78--
Feedback plc1.18m-3.30m2.60m24.00--0.3401--2.20-0.2474-0.24740.08860.57330.1178--7.70---32.88-28.12-35.63-30.7293.3091.80-279.16-312.58--------15.2715.98-13.03--26.72--
Image Scan Holdings Plc2.56m-11.06k3.90m14.00--2.8042.321.52-0.00008-0.000080.01870.01021.072.385.38183,209.30-0.4626-1.15-0.7257-1.7750.5751.36-0.4312-1.011.69--0.00--47.98-3.08145.65--40.19--
Surgical Innovations Group Plc12.54m-622.00k5.13m101.00--0.513263.340.4092-0.0007-0.00070.01340.01070.85252.605.48124,148.50-4.23-8.19-5.38-9.9428.8532.51-4.96-13.310.8677-3.510.1225--5.941.84-292.80--7.20--
Aptamer Group PLC860.00k-2.96m5.28m38.00--1.45--6.14-0.0075-0.00750.00210.00190.31153.783.0322,631.58-107.14---227.63--29.07---343.95--1.17-54.110.4795---50.91--62.25------
Myhealthchecked PLC9.39m-1.04m6.50m10.00--0.8627--0.692-0.0201-0.02010.1810.14491.035.1726.92939,400.00-11.41-7.24-12.91-10.397.9222.82-11.06-5.1311.58--0.0016---50.81368.95-110.48---2.00--
Rua Life Sciences PLC2.19m-1.44m6.67m33.00--0.9289--3.04-0.0551-0.05510.06530.11570.31684.303.9166,393.94-20.82-24.63-22.39-26.8181.06---65.72-97.078.81-23.340.0514--0.550736.4628.11--122.88--
Genincode PLC2.60m-5.94m7.34m36.00--2.61--2.83-0.0507-0.05070.01930.01590.441116.953.4872,194.45-100.88---127.83--49.44---228.70--2.55--0.0849--51.05---26.21------
Cambridge Nutritional Sciences PLC9.77m-328.00k7.61m94.00--0.786523.650.779-0.0015-0.00150.04110.04070.69085.394.62103,978.70-2.32-11.43-2.60-12.9861.8658.79-3.36-26.725.03--0.0151--29.532.2289.66---53.43--
Proteome Sciences plc4.04m-4.08m7.97m35.00------1.98-0.0138-0.01380.0137-0.01780.39274.694.61115,285.70-39.69-1.22----2.1154.53-101.07-2.200.1388-3.701.63---35.3710.52-284.38--126.22--
Verici DX PLC3.35m-3.72m8.23m19.00--1.08--2.45-0.0204-0.02040.01710.03150.4038--5.71239,531.30-44.82---58.12--77.06---110.99------0.0183------23.43------
Genedrive PLC272.00k-5.00m12.08m43.00--2.26--44.43-0.0407-0.04070.00220.00980.0658--1.606,325.58-120.84-97.55-197.86-128.51-----1,837.50-797.031.36-7.490.0789--12.24-50.95-10.16--16.72--
Abingdon Health PLC6.14m-1.27m15.01m85.00--4.37--2.45-0.0104-0.01040.04840.01781.106.384.2872,176.47-22.70-52.46-35.04-85.0059.9735.93-20.72-121.701.70-63.000.3181--51.6721.9263.36---15.69--
Data as of Nov 11 2024. Currency figures normalised to Cambridge Nutritional Sciences PLC's reporting currency: UK Pound GBX

Institutional shareholders

6.46%Per cent of shares held by top holders
HolderShares% Held
Barclays Bank Plc (Private Banking)as of 30 Jun 202311.68m4.91%
Unicorn Asset Management Ltd.as of 30 Sep 20243.70m1.56%
Sterling Investments Management Ltd.as of 31 Oct 20220.000.00%
Data from 31 Oct 2022 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.